Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Melina I Sahay"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 15, Iss 2, Pp FE01-FE04 (2021)
Trelegy Ellipta (GlaxoSmithKlineTM) is the first single inhaler triple combination therapy comprising of umeclidinium, vilanterol and fluticasone approved by the United States Food and Drug Administration (US FDA) for patients with severe COPD in 20
Externí odkaz:
https://doaj.org/article/dd9fcaf543044995bc8398b387bec6c2
Assessment of Corneal Endothelium among Diabetic Patients in a Multispecialty Hospital in Tamil Nadu
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 14, Iss 11, Pp NC01-NC04 (2020)
Introduction: Corneal damage is the common issue affecting 70% of diabetic patients. Diabetic cornea has functional abnormalities such as decreased corneal Endothelial Cell Density (ECD), thicker corneas with increased endothelial permeability, l
Externí odkaz:
https://doaj.org/article/532256ba3bcb40b39b0993b549ad1ad1
Autor:
Ashwin Karuppan, Melina I Sahay, Roshni Ravindranathan, Panguluri Haripriya, Damal Kandadai Sriram, Melvin George
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 13, Iss 2, Pp OC12-OC15 (2019)
Introduction: Diabetes mellitus (DM) is one of the most common non-communicable diseases associated with high morbidity and mortality. Electrolyte disturbances are not uncommon among in-hospital patients with DM. However, there are limited data on th
Externí odkaz:
https://doaj.org/article/b520480786514bbb88ba7220cf9d889a
Autor:
Vishnu Shankar, Pearlsy Grace Rajan, Yuvaraj Krishnamoorthy, Damal Kandadai Sriram, Melvin George, S. Melina I. Sahay, B. Jagan Nathan
Publikováno v:
Irish Journal of Medical Science
Background Development of a prediction model using baseline characteristics of COVID-19 patients at the time of diagnosis will aid us in early identification of the high-risk groups and devise pertinent strategies accordingly. Hence, we did this stud
Autor:
Gautham Devendrapandi, Melina I. Sahay, Deepakrajasekar Padmanaban, Anthoniammal Panneerselvam, Ragasudha Palraj, Rabi Thanikasalam, Sivaranjan kuppan, Vivekanathan Sadaiyandi, Ranjith Balu, Nagappan Rajendiran
Publikováno v:
Inorganic Chemistry Communications. 151:110636
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 15, Iss 2, Pp FE01-FE04 (2021)
Trelegy Ellipta (GlaxoSmithKlineTM) is the first single inhaler triple combination therapy comprising of umeclidinium, vilanterol and fluticasone approved by the United States Food and Drug Administration (US FDA) for patients with severe COPD in 201
Assessment of Corneal Endothelium among Diabetic Patients in a Multispecialty Hospital in Tamil Nadu
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 14, Iss 11, Pp NC01-NC04 (2020)
Introduction: Corneal damage is the common issue affecting 70% of diabetic patients. Diabetic cornea has functional abnormalities such as decreased corneal Endothelial Cell Density (ECD), thicker corneas with increased endothelial permeability, lesse
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :6-7
Eucalyptus oil (EO) is an essential oil which has been used as a traditional remedy in upper respiratory tract infection. It contains approximately 90% cineole and is readily available worldwide in over-the-counter cough drops, liniments, toothpaste,
Autor:
Damal Kandadai Sriram, Ashwin Karuppan, Roshni Ravindranathan, Panguluri Haripriya, Melvin George, Melina I Sahay
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 13, Iss 2, Pp OC12-OC15 (2019)
Introduction: Diabetes mellitus (DM) is one of the most common non-communicable diseases associated with high morbidity and mortality. Electrolyte disturbances are not uncommon among in-hospital patients with DM. However, there are limited data on th
Autor:
Roshini Ravindranath, Melina I Sahay, Damal Kandadai Sriram, Melvin George, Snehalatha Krishnamoorthy
Publikováno v:
International Journal of Basic & Clinical Pharmacology. 9:1153
Brodalumab, a human monoclonal antibody approved as a biological therapy for treating psoriasis. Due to its consistent results across several clinical studies in treating patients with plaque psoriasis, in 2016 it was first approved worldwide in Japa